Status:
UNKNOWN
The Role of Calcipotriol as Radioprotector of Skin
Lead Sponsor:
Rabin Medical Center
Conditions:
Radiodermatitis
Eligibility:
FEMALE
18-75 years
Phase:
PHASE2
Brief Summary
Examining the hypothesis that protecting keratinocytes by calcipotriol can prevent in-vivo cutaneous side effect in patients receiving radiotherapy to the breast. To check the connection between the ...
Detailed Description
STUDY PROTOCOL Fifty women diagnosed with breast cancer planned to receive adjuvant radiotherapy, will participate in the study. About 15 minutes after receiving the daily radiation dose fraction, a ...
Eligibility Criteria
Inclusion
- Age ranging from 18 to 75.
- Confirmed histological diagnosis of Breast cancer.
- Radiotherapy treatment to the breast following lumpectomy.
Exclusion
- Scleroderma.
- An extremely large breast. Interfiled above 25 cm.
- Prior radiotherapy to the same breast, radiotherapy to the contra lateral breast is not a contraindication.
- Mastectomy.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00445250
Last Update
March 8 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petach Tiqva, Israel, 49100